Adaptive Biotechnologies Corp — Director's Dealing 2020

Dec 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-12-11

Reporting Person: SANG CHARLES (SVP, External Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-11	Common Stock	M	50000	$6.55	Acquired	50000	Direct
2020-12-11	Common Stock	S	50000	$56.13	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (Right to Buy)	$6.55	M	50000	Disposed	2028-02-07	Common Stock (50000)	Direct

Footnotes

F1: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.98 to 56.60, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

F2: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.